3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Plasma cell
1
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Genitourinary
1
Gastrointestinal
1
Classical hematology
1
Breast
1
Conditions
Venous Thrombosis
1
Venous Thromboembolism
1
Vascular Diseases
1
Urogenital Neoplasms
1
Thromboembolism
1
Prostatic Neoplasms
1
Neoplasms
1
Myeloproliferative Disorders
1
Multiple Myeloma
1
Lymphoproliferative Disorders
1
Lymphoma
1
Lymphatic Diseases
1
Lung Neoplasms
1
Leukemia
1
Intestinal Neoplasms
1
Hemostatic Disorders
1
Digestive System Neoplasms
1
Colorectal Neoplasms
1
Breast Neoplasms
1
Interventions
Tacrolimus
6
Busulfan
6
fludarabine phosphate
4
fludarabine
4
Peripheral Blood Stem Cell Transplantation
4
Mycophenolic Acid
4
Cyclophosphamide
4
Whole-Body Irradiation
3
ponatinib
2
Patient Reported Outcome Measures
2
Mesna
2
Melphalan
2
Early Intervention, Educational
2
Bone Marrow Transplantation
2
Antilymphocyte Serum
2
Alemtuzumab
2
trametinib
1
ruxolitinib
1
ethanolamine oleate
1
dabrafenib
1
Trimethoprim, Sulfamethoxazole Drug Combination
1
Trimethoprim
1
Tinzaparin
1
Thiotepa
1
Sulfamethoxazole
1
Stem Cell Transplantation
1
Sodium Chloride
1
Sirolimus
1
Saline Solution, Hypertonic
1
Saline Solution
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lymphoproliferative Disorders
×
Tinzaparin
×
Myeloid
×
Clear all
NCT03099031
2019-12-16
PREDICARE
LEO Pharma
Completed
420 enrolled